Dr. Adam Nehemiah Plotnik, MD

Dr. Plotnik practices at Martin Luther King, Jr. Community Hospital in Los Angeles, California, part of County of Los Angeles.

Dr. Plotnik's NPI, 1558621078, was assigned on May 17, 2012. Dr. Plotnik graduated from University of Melbourne Faculty of Medicine in 2002. Dr. Plotnik holds California license A134302.

Dr. Plotnik's primary practice is Martin Luther King, Jr. Community Hospital, at 1680 East 120th Street, Los Angeles, CA 90059 in Los Angeles County. The practice phone is (424) 835-6808.

Dr. Plotnik's primary practice is Martin Luther King, Jr. Community Hospital in Los Angeles, California, part of County of Los Angeles. Dr. Plotnik is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Martin Luther King Jr. Community Medical Group. Dmand AI also links Dr. Plotnik to 2 more hospitals, 3 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Plotnik practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Plotnik's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Plotnik is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dr. Plotnik is licensed in California.

CMS data shows 2,830 Medicare services from Dr. Plotnik across 23 procedure codes in 2024, for 430 Medicare patients. Medicare paid $87,206 for them.

CMS counts 430 Medicare patients who saw Dr. Plotnik in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Plotnik's median patient age at 57, with 47% women.

In 2024, Dr. Plotnik wrote 83 Medicare Part D claims for 29 patients. 94% of them were for generic drugs. CMS names the drug for 72 of them, across 3 drugs with 11 or more claims each, at $274 in total drug cost. In 2023, CMS named 110 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Plotnik for performance year 2024, reported through an alternative payment model (APM). Dr. Plotnik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Plotnik as offering telehealth. CMS counts 11 procedures of leg revascularization (restoring blood flow) by Dr. Plotnik, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Plotnik, published from 2012 to 2020. 2015 was the busiest year, with 2. Dr. Plotnik's most frequent co-authors are Ravi N. Srinivasa, MD, Justin P. McWilliams, MD and Nancy J. Halnon, MD.

CMS Open Payments shows 314 general payments to Dr. Plotnik from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 31% of the total. Siemens Medical Solutions USA, Inc. paid the most, $10,535.

Dr. Plotnik graduated from University of Melbourne Faculty of Medicine in 2002.

Dr. Plotnik is in network with 11 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.